These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8503727)

  • 1. Prolonged activated partial thromboplastin times and detection of the lupus anticoagulant.
    Lucas FV; Miller ML
    Arch Pathol Lab Med; 1993 Jun; 117(6):589-90. PubMed ID: 8503727
    [No Abstract]   [Full Text] [Related]  

  • 2. Lupus anticoagulant testing: effect of the platelet count on the activated partial thromboplastin time.
    Brien WF; Schaus MR; Cooper KE; O'Keefe BT; Inwood M
    Br J Biomed Sci; 1993 Jun; 50(2):114-6. PubMed ID: 8219916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated partial thromboplastin time for automated techniques: a comparison of two commonly used reagents.
    Craig S; Stevenson KJ; Taberner DA
    Br J Biomed Sci; 1994 Dec; 51(4):321-7. PubMed ID: 7756937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated partial thromboplastin time reagents: an evaluation.
    Howarth S
    Br J Biomed Sci; 1993 Jun; 50(2):109-13. PubMed ID: 8219915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of instruments on lupus anticoagulant testing.
    Exner T; Hohnen-Behrens C; Newman P; Dargan W
    Thromb Haemost; 2000 Feb; 83(2):345-8. PubMed ID: 10739397
    [No Abstract]   [Full Text] [Related]  

  • 6. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration in the laboratory profile of a lupus anticoagulant in a patient with non-Hodgkin's lymphoma.
    Moore GW; Kamat AV; Gurney DA; O'Connor O; Rangarajan S; Carr R; Savidge GF
    Clin Lab Haematol; 2004 Dec; 26(6):429-34. PubMed ID: 15596003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a new commercial dilute prothrombin time in the diagnosis of lupus anticoagulants.
    Devreese KM
    Thromb Res; 2008; 123(2):404-11. PubMed ID: 18495217
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenothiazine-induced lupus anticoagulant.
    Kaslow KA; Rosse RB; Zeller JA; Nagy MS; Deustch SI
    J Clin Psychiatry; 1992 Mar; 53(3):103-4. PubMed ID: 1548247
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of sensitivity and specificity of a standardized procedure using different reagents for the detection of lupus anticoagulants. The Working Group on Hemostasis of the Société Française de Biologie Clinique and for the Groupe d'Etudes sur I'Hémostase et la Thrombose.
    Goudemand J; Caron C; De Prost D; Derlon A; Borg JY; Sampol J; Sié P
    Thromb Haemost; 1997 Feb; 77(2):336-42. PubMed ID: 9157593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple kaolin clotting time confirm ratio for the presence of a lupus anticoagulant.
    Williams VK
    Pathology; 2018 Jun; 50(4):457-459. PubMed ID: 29743144
    [No Abstract]   [Full Text] [Related]  

  • 12. Activated protein C resistance assay as a screening test for thromboembolic disposition.
    Shizuka R; Amagai H; Kojima J; Fukumura Y; Kanda T; Kobayashi I
    J Med; 1997; 28(5-6):381-6. PubMed ID: 9604796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing strategies for diagnosing lupus anticoagulant: decision analysis.
    Segal JB; Lehmann HP; Petri M; Mueller L; Kickler TS
    Am J Hematol; 2002 Jul; 70(3):195-205. PubMed ID: 12111765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new dilution for the modified APTT-based assay for activated protein C resistance: improvement of the reliability in patients with a lupus anticoagulant.
    Benattar N; Schved JF; Biron-Andréani C
    Thromb Haemost; 2000 Jun; 83(6):967-8. PubMed ID: 10896260
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential failure of the International Normalized Ratio (INR) System in the monitoring of oral anticoagulation in patients with lupus anticoagulants.
    Della Valle P; Crippa L; Safa O; Tomassini L; Pattarini E; Vigano-D'Angelo S; Grazia Sabbadini M; D'Angelo A
    Ann Med Interne (Paris); 1996 Sep; 147 Suppl 1():10-4. PubMed ID: 8952752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total knee replacement in a patient with lupus anticoagulant.
    Bhagia UT; Corpe RS; Steflik D
    J South Orthop Assoc; 1997; 6(3):231-4. PubMed ID: 9322205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
    Morelli VM; Rodrigues CA; Noguti MA; Matos MF; da Silveira RC; Ribeiro AA; Lourenço DM
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A routine silica-based activated partial thromboplastin time (Hemosil aPTT-SP™) mostly excludes the presence of lupus anticoagulant.
    Mameli A; Barcellona D; Vannini ML; Marongiu F
    Int J Lab Hematol; 2011 Oct; 33(5):e12-3. PubMed ID: 21435191
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant thromboplastin inhibition assay for the detection of lupus anticoagulant.
    Zanon E; Saracino MA; Simioni P; Scarano L; Girolami B; Girolami A
    Clin Lab Haematol; 1995 Sep; 17(3):231-5. PubMed ID: 8719896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of low levels of lupus anticoagulant antibodies.
    Villa P; Mira Y; Ferrando F; Vayá A; Aznar J
    Thromb Res; 2005; 116(5):447-9. PubMed ID: 15925399
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.